« Back
Home /
RS102895

RS102895

Item no.	HY-18611A-1ea
Manufacturer	MedChem Express
CASRN	300815-41-2
Amount	1 ea
Quantity options	100 mg 10 mM/1 mL 10 mg 1 ea 25 mg 50 mg 5 mg
Category	Reagents & Chemicals Biochemicals
Type	Chemicals
Specific against	other
Purity	99.97
Citations	[1]Mirzadegan T, et al. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J Biol Chem. 2000 Aug 18;275(33):25562-71.\|[2]Park J, et al. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells. Am J Physiol Renal Physiol. 2008 Sep;295(3):F749-57.\|[3]Ren F, et al. Analgesic Effect of Intrathecal Administration of Chemokine Receptor CCR2 Antagonist is Related to Change in Spinal NR2B, nNOS, and SIGIRR Expression in Rat with Bone Cancer Pain. Cell Biochem Biophys. 2015 Jun;72(2):611-6. Eur J Pharmacol. 2021, 174165.\|Exp Cell Res. 2020 Nov 1;396(1):112289.\|Hum Reprod. 2019 Apr 1;34(4):646-658.\|J Eur Acad Dermatol Venereol. 2020 Apr;34(4):862-872.\|J Interferon Cytokine Res. 2019 Apr;39(4):224-232. \|J Interferon Cytokine Res. 2020 May;40(5):245-253.\|Life Sci. 2020 Nov 15;261:118360.\|Stem Cell Res Ther. 2021 Jul 2;12(1):378.\|Stem Cell Res Ther. 2025 Mar 1;16(1):108.\|Brain Sci. 2025 Feb 27.\|Cell Death Dis. 2022 Feb 17;13(2):158.\|Int Immunopharmacol. 2023 Feb.\|J Adv Res. 2020 Jul 22;28:231-243.\|J Adv Res. 2024 Apr 14:S2090-1232(24)00155-3.\|J Neuroinflammation. 2023 Nov 17;20(1):270.\|Liver Int. 2022 Sep 27.\|Mol Med Rep. 2017 Sep;16(3):3387-3394. \|Nat Immunol. 2024 Sep 02.\|Sci Adv. 2023 Aug 2;9(31):eadg6856.\|Theranostics. 2020 Apr 27;10(13):5687-5703
Smiles	O=C1NC2=CC=CC=C2C3(CCN(CCC4=CC=C(C(F)(F)F)C=C4)CC3)O1
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Metabolism-sugar/lipid metabolism
Manufacturer - Targets	CCR
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, protect from light)
Molecular Weight	390.40
Product Description	RS102895 is a potent CCR2 antagonist, with an IC50 of 360 nM, and shows no effect on CCR1.
Manufacturer - Research Area	Neurological Disease; Endocrinology
Solubility	DMSO: 175 mg/mL (ultrasonic)\|Ethanol: 50 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturer - Pathway	GPCR/G Protein; Immunology/Inflammation
Isoform	CCR1; CCR2
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-18611A-1ea-safety-datasheet.pdf